Search Results 1591-1600 of 18732 for Activation

  1. A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab Monotherapy in Participants With Select B-Cell Malignancies (MorningSun) - Mayo Clinic

    - Patients with history of macrophage activation syndrome (MAS)/hemophagocytic lymphohistiocytosis (HLH) - Positive test results for chronic hepatitis B ...

  2. Update on the management of ANCA-associated vasculitis - Mayo Clinic

    In this trial, a small molecule (oral agent) inhibitor of the receptor for activated complement factor 5, avacopan, is being compared head-to-head with ...

  3. Medicines that treat ulcerative colitis - Mayo Clinic

    IL-12 and IL-23 activate certain white blood cells and trigger the release of inflammatory signals. In UC, these signals become overactive and drive ongoing ...

  4. Publications - Ronna L. Campbell, M.D., Ph.D. - Mayo Clinic

    Epinephrine and emergency medical services activation recommendations during acute allergic reactions in community settings: International consensus report.

  5. Publications - Ashraf Omar, M.B., B.Ch. - Mayo Clinic

    ... activate cellular stress, innate immune pathways and epithelial to mesenchymal transition. Transpl Immunol. 2021 Dec; 69:101480 Epub 2021 Oct 05. View PubMed ...

  6. Mayo Clinic's Cystic Fibrosis Foundation-designated CF care center

    Normal CFTR regulates and functions as the chloride channel as well as inhibiting activation of the epithelial sodium channel. These effects result in ...

  7. Publications - Michael R. Henry, M.D. - Mayo Clinic

    Frequency of mitogen-activated protein kinase and phosphoinositide 3-kinase signaling pathway pathogenic alterations in EUS-FNA sampled malignant lymph ...

  8. Clinical trials - Oncology (Medical)

    Fibroblast activation protein (FAP) is a cell surface protein that is highly expressed on the surface of cancer-associated fibroblasts (CAFs) present in the ...

  9. Head And Neck Cancers Clinical Trials - Mayo Clinic Research

    ... Activating Notch Mutations Rochester, MN. The primary purpose of this ... 1 in Adenoid Cystic Carcinoma (ACC) patients with activating Notch mutations.

  10. VAL-083 Phase 3 Study in Temozolomide-Avastin (Bevacizumab) Recurrent GBM - Mayo Clinic

    International normalized ratio (INR) ≤ 1.5 and activated partial thromboplastin time (aPTT) ≤ 1.5 x the ULN. QTc <450 msec on screening ECG. No clinically ...